Utility of long-term routine laboratory toxicity monitoring of immunomodulatory drugs in rheumatoid arthritis

1. In this retrospective cohort study involving patients with rheumatoid arthritis on disease-modifying antirheumatic drugs, long-term routine laboratory toxicity monitoring (lt-RLTM) revealed very abnormal results in less than one percent of all completed tests. 2. Most very abnormal laboratory results were already clinically anticipated and were most often due to renal and urinary disorders unrelated […]